{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:04:31Z","timestamp":1791266671487,"version":"4.1.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:00:00Z","timestamp":1429833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123570","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T18:08:41Z","timestamp":1429898921000},"page":"e0123570","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Coverage of the 2011 Q Fever Vaccination Campaign in the Netherlands, Using Retrospective Population-Based Prevalence Estimation of Cardiovascular Risk-Conditions for Chronic Q Fever"],"prefix":"10.1371","volume":"10","author":[{"given":"Patricia E.","family":"Vermeer-de Bondt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teske","family":"Schoffelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Vanrolleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie D.","family":"Isken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Deuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C. J. M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aura","family":"Timen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1017\/S0950268808001908","article-title":"Investigation of a Q fever outbreak in a rural area of The Netherlands","volume":"137","author":"I Karagiannis","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.2807\/ese.17.03.20059-en","article-title":"Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in The Netherlands: from acute to chronic infection","volume":"17","author":"W van der Hoek","year":"2012","journal-title":"Euro Surveill"},{"issue":"9511","key":"ref3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(06)68266-4","article-title":"Q fever","volume":"367","author":"NR Parker","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CMR.12.4.518","article-title":"Q fever","volume":"12","author":"M Maurin","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3201\/eid1804.111478","article-title":"Identification of risk factors for chronic Q fever, the Netherlands","volume":"18","author":"LM Kampschreur","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref6","unstructured":"Human Vaccination Against Q Fever. Publication no 2010\/08: Health Council of the Netherlands; 2010."},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs","volume":"104","author":"BP Marmion","year":"1990","journal-title":"Epidemiol Infect"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.vaccine.2009.02.007","article-title":"Australia's national Q fever vaccination program","volume":"27","author":"HF Gidding","year":"2009","journal-title":"Vaccine"},{"key":"ref9","article-title":"Product Information\u2014TGA approved","year":"2008"},{"key":"ref10","article-title":"Booklet","author":"B Marmion","year":"2009"},{"issue":"23","key":"ref11","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.vaccine.2013.03.062","article-title":"Implementation of a Q fever vaccination program for high-risk patients in the Netherlands","volume":"31","author":"LD Isken","year":"2013","journal-title":"Vaccine"},{"issue":"49","key":"ref12","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1016\/j.vaccine.2014.09.061","article-title":"Adverse events and association with age, sex and immunological parameter of Q fever vaccination in patients at risk for chronic Q fever in the Netherlands 2011","volume":"32","author":"T Schoffelen","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jinf.2013.08.008","article-title":"Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever","volume":"67","author":"T Schoffelen","year":"2013","journal-title":"J Infect"},{"issue":"9596","key":"ref14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"E von Elm","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/fampra\/9.3.330","article-title":"International primary care classifications: the effect of fifteen years of evolution","volume":"9","author":"H Lamberts","year":"1992","journal-title":"Fam Pract"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.7326\/0003-4819-119-10-199311150-00011","article-title":"The introduction of computer-based patient records in The Netherlands","volume":"119","author":"J van der Lei","year":"1993","journal-title":"Ann Intern Med"},{"issue":"4\u20135","key":"ref17","first-page":"339","article-title":"Postmarketing surveillance based on electronic patient records: the IPCI project","volume":"38","author":"AE Vlug","year":"1999","journal-title":"Methods Inf Med"},{"key":"ref18","unstructured":"Human vaccination against Q fever: second advisory report. publication no 2010\/18E: Health Council of the Netherlands; 2010."},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-695X.2011.00876.x","article-title":"The 2007\u20132010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming","volume":"64","author":"F Dijkstra","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.vaccine.2012.03.056","article-title":"Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination?","volume":"30","author":"M Bults","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurpub\/ckt042","article-title":"Vaccine uptake determinants in The Netherlands","volume":"24","author":"A van Lier","year":"2014","journal-title":". Eur J Public Health"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/OLQ.0b013e3181f422bb","article-title":"Hepatitis B vaccination among a national sample of gay and bisexual men","volume":"38","author":"PL Reiter","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"23","key":"ref23","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1016\/j.vaccine.2012.03.055","article-title":"Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination","volume":"30","author":"KK Byrd","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vaccine.2012.11.033","article-title":"The first national adult immunization summit 2012: implementing change through action","volume":"31","author":"AK Shen","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"ref25","first-page":"95","article-title":"Noninfluenza vaccination coverage among adults\u2014United States, 2012","volume":"63","author":"WW Williams","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"ref26","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2014.06.067","article-title":"Determinants of uptake of influenza vaccination among pregnant women\u2014a systematic review","volume":"32","author":"CY Yuen","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"e67866","DOI":"10.1371\/journal.pone.0067866","article-title":"Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands","volume":"8","author":"S Hahn\u00e9","year":"2013","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e5823","DOI":"10.1136\/bmj.e5823","article-title":"Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study","volume":"345","author":"TA Rasmussen","year":"2012","journal-title":"BMJ"},{"issue":"9540","key":"ref29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"VT Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","article-title":"A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease","volume":"24","author":"B Iung","year":"2003","journal-title":"Eur Heart J"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)","volume":"83","author":"JP Singh","year":"1999","journal-title":"Am J Cardiol"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","article-title":"Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample","volume":"21","author":"M Lindroos","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10554-011-9804-7","article-title":"Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies","volume":"27","author":"A Vahanian","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/14779072.1.4.523","article-title":"Etiology of valvular heart disease","volume":"1","author":"H Boudoulas","year":"2003","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"8611","key":"ref35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(88)90649-6","article-title":"Oxford screening programme for abdominal aortic aneurysm in men aged 65 to 74 years","volume":"2","author":"J Collin","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/aje\/154.3.236","article-title":"Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Troms\u00f8 Study","volume":"154","author":"K Singh","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2168.1998.00652.x","article-title":"Results of aortic screening in the brothers of patients who had elective aortic aneurysm repair","volume":"85","author":"Y van der Graaf","year":"1998","journal-title":"Br J Surg"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/bjs.1800780929","article-title":"Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years","volume":"78","author":"RA Scott","year":"1991","journal-title":"Br J Surg"},{"issue":"7649","key":"ref39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/bmj.39517.443796.AD","article-title":"Should we screen for abdominal aortic aneurysm?","volume":"336","author":"S Brearley","year":"2008","journal-title":"Yes. BMJ"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.110.958405","article-title":"Group ESoCAEW. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005","volume":"123","author":"H Dolk","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ahj.2003.05.003","article-title":"Prevalence of congenital heart disease","volume":"147","author":"JI Hoffman","year":"2004","journal-title":"Am Heart J"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.CIR.43.3.323","article-title":"Congenital heart disease in 56,109 births. Incidence and natural history","volume":"43","author":"SC Mitchell","year":"1971","journal-title":"Circulation"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population: changing prevalence and age distribution","volume":"115","author":"AJ Marelli","year":"2007","journal-title":"Circulation"},{"issue":"21","key":"ref44","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","article-title":"Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis","volume":"58","author":"D van der Linde","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ahj.2012.07.023","article-title":"The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation","volume":"164","author":"T van der Bom","year":"2012","journal-title":"Am Heart J"},{"issue":"9","key":"ref46","first-page":"728","article-title":"Epidemiology of infective endocarditis in Spain in the last 20 years","volume":"66","author":"N Fern\u00e1ndez-Hidalgo","year":"2013","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2334-11-48","article-title":"Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system","volume":"11","author":"U Fedeli","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"e000879","DOI":"10.1161\/JAHA.114.000879","article-title":"Racial differences in the prevalence of severe aortic stenosis","volume":"3","author":"DK Patel","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"ref49","first-page":"180","article-title":"A large outbreak of Q fever in the West Midlands: windborne spread into a metropolitan area?","volume":"1","author":"JI Hawker","year":"1998","journal-title":"Commun Dis Public Health"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3201\/eid1007.030724","article-title":"Wind in November, Q fever in December","volume":"10","author":"H Tissot-Dupont","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1017\/S0950268812001203","article-title":"Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak","volume":"141","author":"LM Kampschreur","year":"2013","journal-title":"Epidemiol Infect"},{"key":"ref52","unstructured":"The individual, collective and public importance of vaccination. publication no 2013\/21: Health Council of the Netherlands; 2013."},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3122\/jabfm.2012.04.100274","article-title":"Update on adult immunizations","volume":"25","author":"RM Wolfe","year":"2012","journal-title":"J Am Board Fam Med"},{"issue":"52","key":"ref54","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1016\/j.vaccine.2014.10.008","article-title":"What is the responsibility of national government with respect to vaccination?","volume":"32","author":"M Verweij","year":"2014","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:56:04Z","timestamp":1651798564000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123570"}},"subtitle":[],"editor":[{"given":"James E","family":"Samuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123570","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]}}}